Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Robert Terzoli
ID:
1b834eb6-2619-30fb-68c4
/
Claimed Record
/
Organization:
Seyfarth Shaw LLP
Published Works
21 articles
No Longer the Stuff of Science Fiction: The FDA’s New Policy Approach to Regenerative Medicine Products
BioLoquitur ·
December 11, 2017
cite
Shire v. Amneal – Compound Claim Not Obvious and API Supplier Not Liable Under FDA Safe Harbor
BioLoquitur ·
October 6, 2015
cite
Patent Licensors Beware – No Challenge Clause Does Not Bar Challenge Before the PTAB
BioLoquitur ·
September 28, 2015
cite
Teaching Away Negated by References Disclosing How to Offset Disadvantages
BioLoquitur ·
September 15, 2015
cite
For BioPharma, Citing Relevant Art During Prosecution Does Not Appear to Minimize IPR Risk
BioLoquitur ·
August 31, 2015
cite
Previous
1
2
3
4
5
Next
Practice Areas
Health Care and Life Sciences
Intellectual Property
Government and Public Policy
Technology and AI
Cannabis
Real Estate & Construction
Jurisdictions
North America
United States
